Clinical Trial: A Study of SRSD216 in Patients With Elevated Lipoprotein (a)

U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07172646) titled 'A Study of SRSD216 in Patients With Elevated Lipoprotein (a)' on Aug. 21.

Brief Summary: This is a two-part study, intended to investigate the safety, tolerability, characteristics of PK and PD of single SC dose of SRSD216 and to identify a dose range for further studies in subjects with elevated Lp(a) level with or without ASCVD history.

Study Start Date: April 07

Study Type: INTERVENTIONAL

Condition: Hyperlipoproteinemia (a)

Intervention: DRUG: SRSD216 injection

Administered SC.

DRUG: Placebo

Administered SC.

Recruitment Status: RECRUITING

Sponsor: Sirius Therapeutics Co., Ltd.

Published by HT Digital Content Services...